Answers are grounded in this paper and cite their sources.
Randomized analysis identifies biomarkers linked to diabetic retinopathy through gene expression profiling, suggesting new diagnostic avenues.
Diabetic retinopathy (DR) develops via complex interactions of multiple risk factors and molecular pathways. However, the association between oxidative stress-related genes (OSRGs) and DR progression remains poorly understood. We analyzed two DR datasets (GSE221521, GSE189005) and 986 OSRGs. Differentially expressed genes (DEGs) from GSE221521 were intersected with OSRGs to generate candidate genes; those with protein-protein interaction (PPI) network associations were defined as candidate hub genes. Machine learning further filtered final hub genes, which underwent cross-dataset expression validation. Biomarkers were identified by receiver operating characteristic (ROC) curve analysis (AUC > 0.7) and subjected to nomogram construction, functional annotation, and immune correlation analysis. We obtained 52 candidate genes, 39 of which had PPI interactions. Machine learning yielded 13 final hub genes; CD36, DDIT3, E2F2, NFATC4, and RPL11 showed consistent expression trends across datasets. CD36, DDIT3, E2F2, and RPL11 (AUC > 0.7) were validated as biomarkers, with robust DR predictive performance in nomograms. These genes were enriched in ribosome and spliceosome pathways. Immune infiltration analysis identified three differential cell types: M0 macrophages, monocytes, and activated memory CD4 + T cells. CD36, DDIT3, E2F2, and RPL11 are potential diagnostic biomarkers for DR. The present bioinformatic findings provide preliminary clues for subsequent exploration of DR pathogenesis.
No takes yet. Share an insight, caveat, or question.
Niu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: